JULIE WILLIAMS: Open Payments
NPI 1952427007 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,481 in 122 payments from 19 companies in 2025. Trend: 2023 $2,128 · 2024 $2,671 · 2025 $2,481
Food & beverage: $2,481
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $355 |
| ABBVIE INC. | 18 | $330 |
| Otsuka America Pharmaceutical, Inc. | 14 | $317 |
| Lundbeck LLC | 14 | $280 |
| Neurocrine BioSciences, Inc. | 6 | $180 |
| Alkermes, Inc. | 11 | $177 |
| Axsome Therapeutics, Inc. | 10 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $161 |
| Vanda Pharmaceuticals Inc. | 10 | $140 |
| Janssen Pharmaceuticals, Inc | 3 | $77 |
Products named: REXULTI, CAPLYTA, VRAYLAR, INGREZZA, TRINTELLIX, Auvelity, FANAPT, ARISTADA.
Industry payments across TX — which companies pay providers there.
